Health News

Herpes zoster following a nucleoside-modified messenger RNA COVID-19 vaccine.

PMID: 

Cutis. 2022 Jan ;109(1):E5-E7. PMID: 35180059

Abstract Title: 

Herpes Zoster Following a Nucleoside-Modified Messenger RNA COVID-19 Vaccine.

Abstract: 

Herpes zoster (HZ) was suspected as a predictive cutaneous manifestation of COVID-19, with a debated prognostic significance. We report a series of 5 cases of HZ occurring after vaccination with a nucleoside-modified messenger RNA (mRNA) COVID-19 vaccine (Comirnaty, Pfizer-BioNTech). These new cases do not prove causality between COVID-19 vaccination and HZ. The pathophysiologic mechanism remains elusive, but local vaccine-induced immunomodulation may be involved. The occurrence of HZ does not justify avoiding the second injection of vaccine due to the benefit of vaccination.

read more

Read More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button